13
Less Until None: A Plan for a World without T1D

Less Until None

Embed Size (px)

DESCRIPTION

Presentation by Julia Greenstein PhD, JDRF's Vice President of Cure Therapies, at JDRF New England chapter's 2nd Annual "Living Well with T1D" Symposium on March 9, 2013.

Citation preview

Page 1: Less Until None

Less Until None:

A Planfor a World

without T1D

Page 2: Less Until None

2

LESS UNTIL NONE

2

JDRF’s Vision for the Future

Page 3: Less Until None

3

Therapies CureDelivery of Continuous Therapeutic Improvements

Side-EffectsComplicationsPatient Burden

Glycemic ControlSafety

Normal Physiology Restored

Better Safety, Fewer Side-Effects, Less Exposure to Complications

Page 4: Less Until None

4

JDRF Research Priorities

Regenerating new beta cells

Encapsulation of alternative beta cell sources

Immune therapies

Diagnostic, measurement and imaging tools

Artificial pancreas systems

Novel insulins and other blood sugar control drugs

Diabetic eye disease

Complications prevention

Preventing the autoimmune process from ever starting

Stopping and reversing the autoimmune process early to

maintain insulin independence

Page 5: Less Until None

5

Artificial PancreasAutomated technologies to help maintain better control of blood-glucose levels

Integrated smart technology to automate routine elements of insulin management

FDA released final guidance on pathway for commercialization of devices

Page 6: Less Until None

6

Glucose Responsive Insulin (GRI)

Form of insulin that activated when blood-glucose levels start to rise

Simplifies life for and improves overall blood-glucose controls

JDRF competition underway to accelerate progress on GRI

Page 7: Less Until None

7

EncapsulationEasily implantable Beta cells or islets surrounded by a protective shield/capsule

Able to sense glucose levels and produce insulin as needed

Hidden from the immune system to sustain normal function

Eliminating the need for immunosuppressive drug therapy

Page 8: Less Until None

8

Regeneration

Ability to create new insulin producing cells destroyed by autoimmune attack

Creating abundant supply of Beta cells through stem cells and regeneration

Immune therapy for suspected “triggers” including viruses

Page 9: Less Until None

9

Secondary Prevention

Preserve beta cell function in these newly diagnosed individuals

Approaches include:Reducing inflammationBoosting beta cell survival Suppressing the autoimmune attack

Page 10: Less Until None

10

Primary Prevention

Prevent the autoimmune attack on beta cells before it starts

Approaches include:Viral vaccinesBeta Cell Autoantigen Vaccines

Page 11: Less Until None

11

Funding Scaleand Scope

IndustryInfluence

R&DExpertise

Government Advocacy

Page 12: Less Until None

12

Make a Difference and Get Involved!

Give generously to speed JDRF research to cure, better treat and prevent T1D.

Join a JDRF Walk, Ride, Gala or other fundraising event.

Volunteer at the local JDRF chapter. Participate in clinical research.

Page 13: Less Until None

13

Thank you!